Last $2.69 USD
Change Today +0.0222 / 0.83%
Volume 12.0K
As of 1:34 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Perry A. Karsen

Chief Operations Officer, Executive Vice President and Chief Executive Officer of Celgene Cellular Therapeutics, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 46 board members in 5 different organizations across 10 different industries.

See Board Relationships
58$3,844,160
As of Fiscal Year 2012

Background*

Mr. Perry A. Karsen serves as the President of Stalar 4, Inc. and Stalar 3 Inc. Mr. Karsen has been the Chief Operations Officer at Celgene Corporation since July 2010 and has been its Executive Vice President since February 15, 2012. He serves as an Executive Officer of Healthcare IT, Inc. (also known as Ardais Corporation). He serves as Chief Executive Officer of Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation. He served as the Chief ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: 908-673-9001

Board Members Memberships*

Former Director
Former Director
Former Director
President and Director
President and Director
2011-Present
Director
2013-Present
Director
2014-Present
Director

Education*

Master's Degree
Duke University
BS
University of Illinois-Urbana-Champaign
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Salary$625,000
Total Annual Compensation$625,000

Stock Options*

Restricted Stock Awards$1,018,083
All Other Compensation$18,285
Exercisable Options75,208
Unexercisable Options127,684
Total Number of Options202,892

Total Compensation*

Total Annual Cash Compensation$1,868,254
Total Short Term Compensation$625,000
Other Long Term Compensation$1,036,368
Total Calculated Compensation$3,844,160
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELGZ:US $2.69 USD +0.0222

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.3M
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.3M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer and Director
Shire plc
$2.7M
Haruo Naito Chief Executive Officer, President and Director
Eisai Co., Ltd.
--
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP-CVR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.